11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
In late November of last year, the Court of Chancery in Delaware handed down a decision in a case ca...
Read More >
In some transactions, such as those involving the acquisition of a business, the deal may be documen...
Read More >
Fifth Wall to launch PropTech SPAC - The Real Deal – January 6 - Fifth Wall, a prolific PropTec...
Read More >
In the employment-based immigration context, the Trump Administration’s vision of compressive immig...
Read More >
On September 17, the US Department of the Treasury issued comprehensive proposed regulations to impl...
Read More >
Synopsis: Two Courts of Appeal reach opposite results on ERISA preemption, thus continuing the judic...
Read More >